Cannabics Pharmaceuticals
Bethesda · Founded 2012
About Cannabics Pharmaceuticals
Cannabics Pharmaceuticals (CNBX), a U.S based company, is dedicated to the development of Palliative and personalized Anti-Cancer treatments. The Company's scientific focus is on harnessing the therapeutic properties of natural Cannabinoids. Cannabics' vision is to create tailored therapies for cancer patients, utilizing advanced screening systems and bioinformatic tools. The Company's R&D is based in Israel, where it is licensed by the Ministry of Health and involves both scientific and academic research as well as current medical clinical studies
Company Facts
- Founded: 2012
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2017)
- Ticker: otcqb:CNBX
- Website: cannabics.com
- Phone: +1 (877) 424-2429
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/cannabics-pharmaceuticals-2226952 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.